European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Keywords

MedicineDasatinibNilotinibBosutinibDiscontinuationImatinibMyeloid leukemiaTyrosine-kinase inhibitorInternal medicineOncologyIntensive care medicine

Affiliated Institutions

Related Publications

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Michele Baccarani , Michael Deininger , Gianantonio Rosti +29 more

Abstract Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase inhibitors, mandate regular updating of concepts and management. A European Leuke...

2013 Blood 1953 citations

Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management

Elias Jabbour , Hagop M. Kantarjian

Disease overview : Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1–2 cases per 100,000 adults, and accounts for ∼15% of newly diagnosed ca...

2014 American Journal of Hematology 210 citations

Diagnosing and Managing Advanced Chronic Myeloid Leukemia

Michael W. Deininger

Clinical staging of chronic myeloid leukemia (CML) distinguishes between chronic phase (CP-CML), accelerated phase (AP-CML), and blastic phase (BP-CML), reflecting its natural h...

2015 American Society of Clinical Oncology... 28 citations

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment

Catherine Roche‐Lestienne , Valérie Soenen , Nathalie Grardel +5 more

Abstract Targeting the tyrosine kinase activity ofBCR-ABL represents a very promising therapeutic strategy in chronic myeloid leukemia (CML). Despite strong efficacy of the tyro...

2002 Blood 515 citations

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

Neil P. Shah , John Nicoll , Bhushan Nagar +4 more

2002 Cancer Cell 1614 citations

Publication Info

Year: 2020
Type: review
Volume: 34
Issue: 4
Pages: 966-984
Citations: 1396
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1396

OpenAlex

Cite This

APA Style

                            
                                
                                    Andreas Hochhaus, 
                                
                                    Michele Baccarani, 
                                
                                    Richard T. Silver
                                
                                et al.
                            
                            (2020). 
                            European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. 
                            Leukemia
                            , 34
                            (4)
                            , 966-984.
                            https://doi.org/10.1038/s41375-020-0776-2
                        

Identifiers

DOI: 10.1038/s41375-020-0776-2